Shyamali C Dharmage

From 🇱🇰| Living in 🇦🇺| She/Her | Redmond Barry Distinguished Professor and Head of Allergy and Lung Health Unit @ALHU_MSPGH @UniMelbMDHS @unimelbMSPGH

[Shyamali C Dharmage @CDharmage]

Honoured to be elected as a @AAHMS_health fellow last night. Thank you to all my mentors, collaborators and @ALHU_MSPGH for their important contributions to my career. @UniMelbMDHS @unimelbMSPGH

[Australian Academy of Health and Medical Sciences @AAHMS_health]

A leader in the life course of chronic lung diseases, she has changed global understanding of how lung disease #COPD originates, leading to new practices, policy and a new field of research, pre-COPD.
Welcome Distinguished Prof @Cdharmage as a new #AAHMSFellow. @UniMelbMDHS

[Shyamali C Dharmage @CDharmage]

@donsin4 Well done Rosa. Nice to see that the interest in pre-COPD is exponentially increasing. Let's keep the momentum going until we find interventions to arrest its progression to COPD.

[Shyamali C Dharmage @CDharmage]

I am honoured and humbled to have received this award. Thank you @nhmrc for supporting my research career over two and a half decades.

[NHMRC @nhmrc]

Recipient of the 2025 NHMRC Elizabeth Blackburn Investigator Grant Award for leadership in public health, @CDharmage has dedicated her research career to redefining COPD as a preventable life course condition, shifting the focus from late diagnosis to early intervention. Read more on Professor Dharmage’s career in her own words on our website: https://t.co/k61pM6evc6

[Shyamali C Dharmage @CDharmage]

Congratulations on a landmark paper, @ProfJDChalmers

[James D Chalmers @ProfJDChalmers]

A study 10 years in the making, just published in @LancetRespirMed
How do DPP1 inhibitors really work in bronchiectasis?
We show a novel mechanism for treatment efficacy, by inhibiting Azurocidin-1, a ciliotoxin, DPP1i can enhance mucociliary clearance.
https://t.co/eVR7fhgW7w

[Shyamali C Dharmage @CDharmage]

I am honoured and deeply humbled by Elizabeth Blackburn Award for Leadership in Public Health. Thank you @NHMRC for supporting my career and research for nearly 2.5 decades.

[NHMRC @nhmrc]

Congratulations to each of the 2025 Research Excellence Awardees honoured tonight for their success and thank you for sharing NHMRC’s vision of building a Healthy Australia. Read the full list of award winners on our website: https://t.co/hv2CkG9qxl

[Shyamali C Dharmage @CDharmage]

@ProfJDChalmers It was an inspiring presentation @ProfJDChalmers. You are such an excellent presenter too.

[Shyamali C Dharmage @CDharmage]

@ProfJDChalmers @LancetRespirMed Great paper !!

[James D Chalmers @ProfJDChalmers]

Our latest paper just out in @LancetRespirMed
10 unanswered questions about DPP1 inhibition in bronchiectasis

We outline key future clinical and research questions after the approval of the first new therapy for people with bronchiectasis.
Congratulations Jiahui, Chloe and @MereteLong

[Shyamali C Dharmage @CDharmage]

Honoured to be highlighted by @nhmrc . Thank you for supporting our research.

[NHMRC @nhmrc]

Chronic Obstructive Pulmonary Disease (COPD) is common and treatable but often diagnosed too late. NHMRC funded researcher Professor Shyamali Dharmage (@MDHS_UniMelb) is leading a world first trial of triple therapy to halt lung damage in pre-COPD #WorldCOPDDay

[Shyamali C Dharmage @CDharmage]

Stay tuned for Cure-Adire. Time that we put our resources together. Funded by MRFF, this project will commence in early 2026. As the lead, I like to thank all the PIs of respiratory studies for coming together for this grant application.

[Asthma Australia @AsthmaAustralia]

Professor Gary Anderson tells us about CURE ADIRE

[Asthma Australia @AsthmaAustralia]

Excited to learn about CURE-AIDRE which is a database of 75,000 asthma samples, decades in the making. It will be the engine to drive the search for treatments and cure. @CDharmage @tomiosifidis

[Shyamali C Dharmage @CDharmage]

@FrancyPolverino @EvaPolverino @EuroRespSoc @EMBARCnetwork ❤️

[Peeref @Peeref1]

🔓Now on Peeref: Paternal prepubertal passive smoke exposure is related to impaired lung function trajectories from childhood to middle age in their offspring
🔗: https://t.co/K8Z4ZICcX6
👁️: Altmetric: 285
@CDharmage @mishra_gita @ThoraxBMJ

[Don Sin @donsin4]

I will be speaking on the role of biologics in #COPD as someone who is not funded by pharma

[Shyamali C Dharmage @CDharmage]

Thanks for highlighting this important work

[Healio Pulmonology @HealioPulm]

💬"Exposure to passive (second-hand) smoke🚬 not only harms the children at that time but may also affect the lung health of their future children,” Dinh S. Bui, PhD, and @CDharmage, MBBS, MSc, MD, PhD, @unimelbMSPGH, told Healio.
https://t.co/GuxObLGUo0

[Shyamali C Dharmage @CDharmage]

@FrancyPolverino @AnnualReviews @donsin4 @BCMFromtheLabs @BCMDeptMedicine @bcmhouston Congratulations 🙌

[Shyamali C Dharmage @CDharmage]

@ProfJDChalmers 😧

[Shyamali C Dharmage @CDharmage]

Lets promote and advance the field of pre-COPD. Recognising and tackling the pre-disease and early disease states have helped reducing the burden of many chronic diseases, so why not in COPD? https://t.co/Jn1DrYTpV5

[Shyamali C Dharmage @CDharmage]

@DrPLungResearch @LancetRespirMed Thanks 🙏 Paul.

[Shyamali C Dharmage @CDharmage]

Grateful to @LancetRespirMed for the kind profile. Honoured and humbled to be featured. Thank you.
Shyamali Dharmage: mapping lung health trajectories across the life course - The Lancet Respiratory Medicine https://t.co/v9tQDJYk7o

[Shyamali C Dharmage @CDharmage]

@FrancyPolverino @LancetRespirMed Thank you Francy. Looking forward to working with you again in the not-too-distant future. Take care ❤️

[Shyamali C Dharmage @CDharmage]

@faner_rosa @LancetRespirMed Thank you 🙏. Fortunate to have you in my life as a key collaborator and a friend.